retatrutide trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a AllWell - This is exciting.

GLP-1 receptor agonists are effective treatment options for managing blood sugar levels and promoting weight loss in patients who suffer from type 2 diabetes and obesity

If you are considering stopping the medication, say so

Now, were learning its entirely possible and maybe even beneficial in the long run for certain people to dial down the dose and microdose their GLP-1

The development of dependable biomarkers to estimate therapy response and enhance patient selection constitutes another substantial unmet need, since individual responses to GLP-1 treatments might differ markedly

223 Recently, a study found that alpha-TC1/6 cells can secrete GLP-1 under hyperglycemic, hyperlipidemic or inflammatory conditions during in vitro experiments, suggesting that this hormone may act locally to influence both islet alpha- and beta-cell behaviour during pathological conditions